GSK : Japan's Ministry of Health, Labour and Welfare accepts Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at increased risk - Form 6-K -December 12, 2023 at 06:09 am EST

a3878w

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


Form 6-K


REPORT OF FOREIGN PRIVATE ISSUER...

Related Keywords

Japan ,Philadelphia ,Pennsylvania ,United States ,London ,City Of ,United Kingdom ,Canada ,Washington ,Brentford ,Hounslow ,Middlesex ,United Kingdom General ,Steph Mountifield ,Camilla Campbell ,Josh Williams ,Tim Foley ,Richard Osei Yeboah ,Simon Moore ,J Clin Virol ,Jeff Mclaughlin ,Mick Readey ,Nick Stone ,James Dodwell ,Kathleen Quinn ,Japan Ministry Of Health ,Advisory Committee On Immunization Practices ,Antigenics Inc ,Securities Exchange ,Us Centers For Disease ,Centers For Disease ,Agenus Inc ,Saponiqx Inc ,Commission File Number ,File Number ,West Road ,London United Kingdom ,Disease Control ,Advisory Committee ,Immunization Practices ,Product Information ,Annual Report ,Jy Respiratory ,New Englj Med ,Older Adults ,Chronic Medical Conditions ,Clin Infect Dis ,Securities Exchange Act ,Markets ,